Filing Details
- Accession Number:
- 0001214659-19-005436
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-23 18:07:23
- Reporting Period:
- 2019-08-22
- Accepted Time:
- 2019-08-23 18:07:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576263 | Mirati Therapeutics Inc. | MRTX | Pharmaceutical Preparations (2834) | 462693615 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1579824 | M Charles Baum | C/O Mirati Therapeutics Inc. 9393 Towne Centre Drive, Ste 200 San Diego CA 92121 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-22 | 51,810 | $8.50 | 117,851 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-22 | 11,843 | $85.03 | 106,008 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 28,446 | $85.89 | 77,562 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 3,619 | $86.58 | 73,943 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 4,544 | $88.24 | 69,399 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 1,622 | $89.24 | 67,777 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 1,736 | $91.12 | 66,041 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-08-22 | 2 | $5.40 | 66,043 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-08-22 | 556 | $24.99 | 66,599 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy) | Disposition | 2019-08-22 | 51,810 | $0.00 | 51,810 | $8.50 |
| Common Stock | Stock Option (Right to buy) | Disposition | 2019-08-22 | 2 | $0.00 | 2 | $5.40 |
| Common Stock | Stock Option (Right to buy) | Disposition | 2019-08-22 | 556 | $0.00 | 556 | $24.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-07-16 | No | 4 | M | Direct | |
| 109,996 | 2027-01-25 | No | 4 | M | Direct | |
| 114,365 | 2026-01-21 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017.
- This transaction was executed in multiple trades at prices ranging from $84.38 to $85.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $85.390 to $86.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $86.390 to $86.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $87.92 to $88.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $89.05 to $90.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $90.77 to $91.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- 20% of the shares subject to the stock option vested and became exercisable on the date of grant and 20% of the shares vested on each of the 1st 2nd, 3rd and 4th anniversaries of November 12, 2012. The options expire on July 16, 2020.
- 25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.
Billionaire Hedge Funds
